Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Int J Cancer. 2023 May 4;153(3):552–570. doi: 10.1002/ijc.34528

Fig. 8.

Fig. 8

Overall hypothesis: KMT2D links TGF-β and activin A signaling. TGF-β induces KMT2D mRNA degradation by the upregulation of miR-147b. Decreased expression of KMT2D subsequently upregulates the transcription of INHBA/activin A, which then promotes EMT, cell migration and invasion, tumorigenicity, PDAC progression, and metastasis via a p38-mediated non-canonical pathway.